An innovative, Sudbury-developed medical device is getting a boost from the federal government to help develop and take the product to commercial market.
Flosonics Medical is receiving $200,000 to help develop the device, an Automated Fluid Response Ultrasound system.
The system determines whether intravenous fluids are a viable and effective treatment option for critically ill patients. In addition to supporting the research and development of the product, the investment will also assist with clinical trials and preliminary market development.
"This exciting initiative will allow us to capitalize on an immediate opportunity to develop a wearable medical device that will enable healthcare providers to better care for critically ill patients,” said Andrew Eibl, COO and co-founder of Flosonics, in a news release.
“We are pleased to partner with the Government of Canada to develop our FloPatch technology and we look forward to the positive impact it will have on healthcare delivery in Canada and beyond."
The funding comes from FedNor’s Northern Ontario Development Program.
